首页>
外国专利>
METHOD OF EVALUATING GLIOBLASTOMA MULTIFORME PATIENT APPLICABLE TO IMMUNOTHERAPY TREATMENT BASED ON DENDRITIC CELL TUMOR VACCINES AND METHOD OF PROGNOSTICATING SURVIVAL RATE IN GLIOBLASTOMA MULTIFORME PATIENT AFTER TREATMENT
METHOD OF EVALUATING GLIOBLASTOMA MULTIFORME PATIENT APPLICABLE TO IMMUNOTHERAPY TREATMENT BASED ON DENDRITIC CELL TUMOR VACCINES AND METHOD OF PROGNOSTICATING SURVIVAL RATE IN GLIOBLASTOMA MULTIFORME PATIENT AFTER TREATMENT
A method of evaluating if a glioblastoma multiforme (GBM) patient is applicable to be treated with an immunotherapy based on dendritic cell tumor vaccines includes a sample obtaining step to obtain a sample from the GBM patient, a detecting step to detect an expression level of a biomarker, and a comparing step to compare the expression level of the biomarker to a threshold, wherein the GBM patient is applicable to treat with the immunotherapy based on dendritic cell tumor vaccines when the expression level of the biomarker is lower than the threshold. A method of prognosticating a survival rate in the GBM patient after a treatment includes a sample obtaining step, a detecting step, and a comparing step, wherein the GBM patient is determined to have a good prognosis after the treatment when the expression level of the sample from the GBM is lower than the threshold.
展开▼
